Capital Expenditures for Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's current capital expenditures (TTM) is $563.00M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
GILD
Currently viewingCapital ExpendituresSwitch metric
Latest period
$563.00M
YoY change
+7.6%
5Y CAGR
-2.8%
Peak year (2018)
$924.00M
Cumulative capital expenditures
$9.58B
CapEx history chart for Gilead Sciences (GILD) from 1990 to 2025
CapEx history table for Gilead Sciences (GILD) from 1990 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $563.00M | +7.6% | ||
| 2024 | $523.00M | -10.6% | ||
| 2023 | $585.00M | -19.6% | ||
| 2022 | $728.00M | +25.7% | ||
| 2021 | $579.00M | -10.9% | ||
| 2020 | $650.00M | -21.2% | ||
| 2019 | $825.00M | -10.7% | ||
| 2018 | $924.00M | +56.6% | ||
| 2017 | $590.00M | -21.1% | ||
| 2016 | $748.00M | +0.1% | ||
| 2015 | $747.00M | +34.1% | ||
| 2014 | $557.00M | +193.2% | ||
| 2013 | $190.00M | -52.1% | ||
| 2012 | $397.00M | +201.0% | ||
| 2011 | $131.90M | +113.1% | ||
| 2010 | $61.88M | -73.1% | ||
| 2009 | $230.06M | +100.0% | ||
| 2008 | $115.00M | +46.2% | ||
| 2007 | $78.65M | -25.2% | ||
| 2006 | $105.21M | +119.4% | ||
| 2005 | $47.95M | -6.6% | ||
| 2004 | $51.37M | +33.0% | ||
| 2003 | $38.61M | +119.4% | ||
| 2002 | $17.60M | -33.2% | ||
| 2001 | $26.33M | +68.6% | ||
| 2000 | $15.62M | +25.0% | ||
| 1999 | $12.50M | +13.6% | ||
| 1998 | $11.00M | -20.3% | ||
| 1997 | $13.80M | +273.0% | ||
| 1996 | $3.70M | +516.7% | ||
| 1995 | $600,000 | -84.6% | ||
| 1994 | $3.90M | — | ||
| 1992 | $4.40M | +780.0% | ||
| 1991 | $500,000 | +66.7% | ||
| 1990 | $300,000 | — |
CapEx values are taken from Gilead Sciences's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Gilead Sciences (GILD) capital expenditures totalled $563.00M – grew 7.6% year-over-year.
Gilead Sciences capital expenditures has contracted on net over the period, with a -2.8% compound annual growth rate over 2020–2025 (5 years).
Gilead Sciences capital expenditures peaked at $924.00M in 2018; the latest annual figure is $563.00M in 2025 (39.1% below peak).
2018 marks the peak capital expenditures at $924.00M, with the historical low of $300,000 recorded in 1990.
Among 8 Healthcare peers, Gilead Sciences (GILD) ranks 9th; the peer median for capital expenditures is $3.87B.
Gilead Sciences Capital Expenditures by Year
Gilead Sciences Capital Expenditures 2025: $563.00M
Gilead Sciences capital expenditures in 2025 was $563.00M, grew 7.6% from 2024.
Gilead Sciences Capital Expenditures 2024: $523.00M
Gilead Sciences capital expenditures in 2024 was $523.00M, declined 10.6% below 2023.
Gilead Sciences Capital Expenditures 2023: $585.00M
Gilead Sciences capital expenditures in 2023 was $585.00M, declined 19.6% below 2022.
Gilead Sciences Capital Expenditures 2022: $728.00M
Gilead Sciences capital expenditures in 2022 was $728.00M, grew 25.7% from 2021.
Gilead Sciences Capital Expenditures 2021: $579.00M
Gilead Sciences capital expenditures in 2021 was $579.00M.
See more financial history for Gilead Sciences (GILD).
Sector peers — CapEx
Companies in the same sector as Gilead Sciences, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Gilead Sciences's capital expenditures?
- Latest reported capital expenditures for Gilead Sciences (GILD) is $563.00M (period ending December 31, 2025).
How has Gilead Sciences capital expenditures changed year-over-year?
- Gilead Sciences (GILD) capital expenditures changed +7.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Gilead Sciences capital expenditures?
- Gilead Sciences (GILD) capital expenditures compound annual growth rate is -2.8% over the most recent 5 years available.
When did Gilead Sciences capital expenditures hit its highest annual value?
- Gilead Sciences capital expenditures reached its highest annual value of $924.00M in 2018.
What was Gilead Sciences capital expenditures in 2024?
- Gilead Sciences (GILD) capital expenditures in 2024 was $523.00M.
What was Gilead Sciences capital expenditures in 2025?
- Gilead Sciences (GILD) capital expenditures in 2025 was $563.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
GILD Overview
Company profile, financial tools, and key metrics
GILD Revenue Counter
Earns $933.60 every second. See per minute, hour, and day.
GILD Earnings Counter
Earns $269.85 per second net profit. See per minute, hour, and day.
GILD Economic Scale
Exceeds Albania's GDP. Compare with world economies.
GILD What If Invested
What if you had invested $1,000? See historical returns from any date.
GILD How It Makes Money
Discover visual breakdown of $29.44B in revenue — where it comes from and where it goes.
GILD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
GILD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
GILD Daily Price Character
Explosive · 48.7% historical win rate (green days). Streaks & record days.
GILD Buybacks
1.26% TTM buyback yield. Shareholder yield & SBC comparison.
GILD Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
GILD Dividend Profile
Yield: 2.48%. Safety: 8/8. See full history.
GILD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
GILD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.